Dictating Phenotype, Function, and Fate of Human T Cells with Co‐Stimulatory Antibodies Presented by Filamentous Immune Cell Mimics

T cells require a co‐stimulatory signal in addition to T‐cell receptor (TCR) stimulation to achieve full activation. While most studies focus on the co‐stimulatory receptor CD28, little is known about the role of the other co‐stimulatory receptors in T‐cell signaling. A deeper understanding of how co‐stimulatory receptor signaling cooperates with TCR signaling could improve the ability to control T‐cell function and benefit the design of T‐cell based immunotherapies. Artificial antigen presenting cells (aAPCs) enable tight control over the signals given to T cells. In this study, filamentous polyisocyanopeptide (PIC) polymers (immunofilaments) are used as nanosized aAPCs to study the role of the engagement of six distinct co‐stimulatory molecules on human T‐cell phenotype, function, and fate in the context of TCR signaling. The immunofilaments highlight important roles for CD28 and CD2 signaling in T‐cell priming, proliferation, cytokine production, and multifunctionality. Taken together, this work provides insight into the role of combined TCR and co‐stimulation on T‐cell phenotype, function, and fate using immunofilaments. Notably, the findings on the roles of co‐stimulatory molecule function can be used for the rational design of future cancer immunotherapies.

[1]  M. Cragg,et al.  TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activity , 2021, Communications biology.

[2]  Michael Loran Dustin,et al.  A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals , 2020, Nature Immunology.

[3]  Ronnie H. Fang,et al.  Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy , 2019, Theranostics.

[4]  Alan E. Rowan,et al.  Cytokine‐Functionalized Synthetic Dendritic Cells for T Cell Targeted Immunotherapies , 2018, Advanced Therapeutics.

[5]  Andrew Z. Wang,et al.  A Dual Immunotherapy Nanoparticle Improves T‐Cell Activation and Cancer Immunotherapy , 2018, Advanced materials.

[6]  C. Figdor,et al.  Affinity-Based Purification of Polyisocyanopeptide Bioconjugates. , 2017, Bioconjugate chemistry.

[7]  C. Figdor,et al.  Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect , 2017, ACS omega.

[8]  J. Tabernero,et al.  The expanding role of immunotherapy. , 2017, Cancer treatment reviews.

[9]  M. Bylesjo,et al.  Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab , 2015, Journal of Immunotherapy for Cancer.

[10]  E. Wherry,et al.  Molecular and cellular insights into T cell exhaustion , 2015, Nature Reviews Immunology.

[11]  J. Borst,et al.  Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential. , 2015, Immunotherapy.

[12]  R. Kaplan,et al.  4-1BB Costimulation Ameliorates T Cell Exhaustion Induced by Tonic Signaling of Chimeric Antigen Receptors , 2015, Nature Medicine.

[13]  C. Figdor,et al.  Polymer-based synthetic dendritic cells for tailoring robust and multifunctional T cell responses. , 2015, ACS chemical biology.

[14]  C. Figdor,et al.  Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells , 2014, Trends in biotechnology.

[15]  A. Rogel,et al.  Differential Impact of CD27 and 4-1BB Costimulation on Effector and Memory CD8 T Cell Generation following Peptide Immunization , 2014, The Journal of Immunology.

[16]  F. Sallusto,et al.  The who's who of T‐cell differentiation: Human memory T‐cell subsets , 2013, European journal of immunology.

[17]  C. Figdor,et al.  Therapeutic nanoworms: towards novel synthetic dendritic cells for immunotherapy , 2013 .

[18]  Lieping Chen,et al.  Molecular mechanisms of T cell co-stimulation and co-inhibition , 2013, Nature Reviews Immunology.

[19]  C. Figdor,et al.  The nature of activatory and tolerogenic dendritic cell-derived signal II , 2013, Front. Immunol..

[20]  F. Meng,et al.  Latex bead-based artificial antigen-presenting cells induce tumor-specific CTL responses in the native T-cell repertoires and inhibit tumor growth. , 2013, Immunology letters.

[21]  L. Poulsen,et al.  IL-1 Family Members IL-18 and IL-33 Upregulate the Inflammatory Potential of Differentiated Human Th1 and Th2 Cultures , 2012, The Journal of Immunology.

[22]  C. Sautès-Fridman,et al.  The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.

[23]  Steven A. Rosenberg,et al.  Adoptive immunotherapy for cancer: harnessing the T cell response , 2012, Nature Reviews Immunology.

[24]  C. Brightling,et al.  Translating Basic Research Into Clinical Practice CHEST , 2012 .

[25]  D. Schendel,et al.  Third generation dendritic cell vaccines for tumor immunotherapy. , 2012, European journal of cell biology.

[26]  H. Abken,et al.  Costimulation by chimeric antigen receptors revisited the T cell antitumor response benefits from combined CD28‐OX40 signalling , 2011, International journal of cancer.

[27]  S. Tangye,et al.  SLAM family receptors and SAP adaptors in immunity. , 2011, Annual review of immunology.

[28]  O. Majdic,et al.  T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells , 2010, Journal of immunological methods.

[29]  J. Curtsinger,et al.  Inflammatory cytokines as a third signal for T cell activation. , 2010, Current opinion in immunology.

[30]  P. Hwu,et al.  T helper 17 cells promote cytotoxic T cell activation in tumor immunity. , 2009, Immunity.

[31]  Anna M. Keller,et al.  Costimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting. , 2009, Blood.

[32]  Michael L. Dustin,et al.  JCB_200809136 521..534 , 2009 .

[33]  Lance C Kam,et al.  Micropatterning of costimulatory ligands enhances CD4+ T cell function , 2008, Proceedings of the National Academy of Sciences.

[34]  M. Roederer,et al.  T-cell quality in memory and protection: implications for vaccine design , 2008, Nature Reviews Immunology.

[35]  Mario Roederer,et al.  Frontline : Polyfunctional T cell responses are a hallmark of HIV-2 infection , 2008 .

[36]  H. Rammensee,et al.  Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells , 2007, Cancer Immunology, Immunotherapy.

[37]  Brigitta Stockinger,et al.  Differentiation and function of Th17 T cells. , 2007, Current opinion in immunology.

[38]  B. Hill,et al.  SAP Regulates TH2 Differentiation and PKC-θ-Mediated Activation of NF-κB1 , 2004 .

[39]  T. Rowley,et al.  Stimulation by Soluble CD70 Promotes Strong Primary and Secondary CD8+ Cytotoxic T Cell Responses In Vivo 1 , 2004, The Journal of Immunology.

[40]  J. Gribben,et al.  Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.